A Real-World Study of Tofacitinib in Indian Patients with Refractory Moderate-to-Severe Atopic Dermatitis, its Economic Considerations and Immunological Rationale
Background: The response of atopic dermatitis (AD) to different biologics and JAK inhibitors (JAKibs) is variable due to the varied immunological endotypes of AD. Aim and Objectives: To assess the effectiveness and adverse effect profile of tofacitinib in recalcitrant, moderate-to-severe AD patients...
Zapisane w:
| Główni autorzy: | , , , , |
|---|---|
| Format: | Artigo |
| Język: | Inglês |
| Wydane: |
Wolters Kluwer Medknow Publications
2025-05-01
|
| Seria: | Indian Dermatology Online Journal |
| Hasła przedmiotowe: | |
| Dostęp online: | https://journals.lww.com/10.4103/idoj.idoj_665_24 |
| Etykiety: |
Nie ma etykietki, Dołącz pierwszą etykiete!
|